Automated Author ProfileNolan, Jerry P.
Nolan, Jerry P.
Current S-Index
Sum of Dataset Indices for all datasets
Average Dataset Index per Dataset
Average Dataset Index per dataset
Total Datasets
Total datasets for this author
Average FAIR Score
Average FAIR Score per dataset
Total Citations
Total citations to the author's datasets
Total Mentions
Total mentions of the author's datasets
S-Index Interpretation
The S-Index (Sharing Index) is a comprehensive metric that represents the cumulative impact of all your datasets. It is calculated as the sum of Dataset Index scores across all your claimed datasets.
What it means:
- A higher S-index indicates greater overall impact of your datasets relative to typical datasets in their fields of research
- The S-Index grows as you add more datasets or as existing datasets gain more citations and mentions
- It provides a single number to track your research data impact over time
Current S-Index: 7.7 (sum of 12 datasets Dataset Index scores)
More information here.
S-Index Over Time
Cumulative Citations Over Time
Cumulative Mentions Over Time
Datasets
Additional file 1. PARAMEDIC2 HEALTH ECONOMICS ANALYSIS PLAN. Details of the PARAMEDIC2 health economics analysis plan.
Authors
- Achana, Felix ;
- Petrou, Stavros ;
- Madan, Jason ;
- Khan, Kamran ;
- Ji, Chen ;
- Anower Hossain ;
- Lall, Ranjit ;
- Slowther, Anne-Marie ;
- Deakin, Charles D. ;
- Quinn, Tom ;
- Nolan, Jerry P. ;
- Pocock, Helen ;
- Rees, Nigel ;
- Smyth, Michael ;
- Gates, Simon ;
- Gardiner, Dale ;
- Perkins, Gavin D.
Additional file 2. Unit costs for NHS, non-NHS and personal and social service resource inputs (£ sterling, 2017 prices). Unit costs data used to inform the within trial economic evaluation.
Authors
- Achana, Felix ;
- Petrou, Stavros ;
- Madan, Jason ;
- Khan, Kamran ;
- Ji, Chen ;
- Anower Hossain ;
- Lall, Ranjit ;
- Slowther, Anne-Marie ;
- Deakin, Charles D. ;
- Quinn, Tom ;
- Nolan, Jerry P. ;
- Pocock, Helen ;
- Rees, Nigel ;
- Smyth, Michael ;
- Gates, Simon ;
- Gardiner, Dale ;
- Perkins, Gavin D.
Additional file 3. Pre-specified and post-hoc sensitivity analyses exploring varying features of the within-trial economic evaluation on the cost-effectiveness results. List of sensitivity analyses.
Authors
- Achana, Felix ;
- Petrou, Stavros ;
- Madan, Jason ;
- Khan, Kamran ;
- Ji, Chen ;
- Anower Hossain ;
- Lall, Ranjit ;
- Slowther, Anne-Marie ;
- Deakin, Charles D. ;
- Quinn, Tom ;
- Nolan, Jerry P. ;
- Pocock, Helen ;
- Rees, Nigel ;
- Smyth, Michael ;
- Gates, Simon ;
- Gardiner, Dale ;
- Perkins, Gavin D.
Additional file 5. Economic modelling to extrapolate cost-effectiveness beyond trial follow-up and incorporate the indirect effects of organ donation. List of subgroup analyses.
Authors
- Achana, Felix ;
- Petrou, Stavros ;
- Madan, Jason ;
- Khan, Kamran ;
- Ji, Chen ;
- Anower Hossain ;
- Lall, Ranjit ;
- Slowther, Anne-Marie ;
- Deakin, Charles D. ;
- Quinn, Tom ;
- Nolan, Jerry P. ;
- Pocock, Helen ;
- Rees, Nigel ;
- Smyth, Michael ;
- Gates, Simon ;
- Gardiner, Dale ;
- Perkins, Gavin D.
Additional file 4. Subgroup analyses conducted that explored potential heterogeneity in the within-trial incremental cost-effectiveness of adrenaline.
Authors
- Achana, Felix ;
- Petrou, Stavros ;
- Madan, Jason ;
- Khan, Kamran ;
- Ji, Chen ;
- Anower Hossain ;
- Lall, Ranjit ;
- Slowther, Anne-Marie ;
- Deakin, Charles D. ;
- Quinn, Tom ;
- Nolan, Jerry P. ;
- Pocock, Helen ;
- Rees, Nigel ;
- Smyth, Michael ;
- Gates, Simon ;
- Gardiner, Dale ;
- Perkins, Gavin D.
Additional file 6. Resources use for NHS and personal and social services by trial arm in the 6 month post-randomisation period; all patients. Resource use results table, within-trial economic evaluation.
Authors
- Achana, Felix ;
- Petrou, Stavros ;
- Madan, Jason ;
- Khan, Kamran ;
- Ji, Chen ;
- Anower Hossain ;
- Lall, Ranjit ;
- Slowther, Anne-Marie ;
- Deakin, Charles D. ;
- Quinn, Tom ;
- Nolan, Jerry P. ;
- Pocock, Helen ;
- Rees, Nigel ;
- Smyth, Michael ;
- Gates, Simon ;
- Gardiner, Dale ;
- Perkins, Gavin D.
Additional file 2. Unit costs for NHS, non-NHS and personal and social service resource inputs (£ sterling, 2017 prices). Unit costs data used to inform the within trial economic evaluation.
Authors
- Achana, Felix ;
- Petrou, Stavros ;
- Madan, Jason ;
- Khan, Kamran ;
- Ji, Chen ;
- Anower Hossain ;
- Lall, Ranjit ;
- Slowther, Anne-Marie ;
- Deakin, Charles D. ;
- Quinn, Tom ;
- Nolan, Jerry P. ;
- Pocock, Helen ;
- Rees, Nigel ;
- Smyth, Michael ;
- Gates, Simon ;
- Gardiner, Dale ;
- Perkins, Gavin D.
Additional file 3. Pre-specified and post-hoc sensitivity analyses exploring varying features of the within-trial economic evaluation on the cost-effectiveness results. List of sensitivity analyses.
Authors
- Achana, Felix ;
- Petrou, Stavros ;
- Madan, Jason ;
- Khan, Kamran ;
- Ji, Chen ;
- Anower Hossain ;
- Lall, Ranjit ;
- Slowther, Anne-Marie ;
- Deakin, Charles D. ;
- Quinn, Tom ;
- Nolan, Jerry P. ;
- Pocock, Helen ;
- Rees, Nigel ;
- Smyth, Michael ;
- Gates, Simon ;
- Gardiner, Dale ;
- Perkins, Gavin D.
Additional file 5. Economic modelling to extrapolate cost-effectiveness beyond trial follow-up and incorporate the indirect effects of organ donation. List of subgroup analyses.
Authors
- Achana, Felix ;
- Petrou, Stavros ;
- Madan, Jason ;
- Khan, Kamran ;
- Ji, Chen ;
- Anower Hossain ;
- Lall, Ranjit ;
- Slowther, Anne-Marie ;
- Deakin, Charles D. ;
- Quinn, Tom ;
- Nolan, Jerry P. ;
- Pocock, Helen ;
- Rees, Nigel ;
- Smyth, Michael ;
- Gates, Simon ;
- Gardiner, Dale ;
- Perkins, Gavin D.
Additional file 4. Subgroup analyses conducted that explored potential heterogeneity in the within-trial incremental cost-effectiveness of adrenaline.
Authors
- Achana, Felix ;
- Petrou, Stavros ;
- Madan, Jason ;
- Khan, Kamran ;
- Ji, Chen ;
- Anower Hossain ;
- Lall, Ranjit ;
- Slowther, Anne-Marie ;
- Deakin, Charles D. ;
- Quinn, Tom ;
- Nolan, Jerry P. ;
- Pocock, Helen ;
- Rees, Nigel ;
- Smyth, Michael ;
- Gates, Simon ;
- Gardiner, Dale ;
- Perkins, Gavin D.